Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

2 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellNW\3UIJyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1f0RmlEPTB;MD6wNFAxODByM{W5JO69VQ>?M1;zVnNCVkeHUh?=
MV-4-11MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\LRWlEPTB;MD6wNFAxQTV4IN88US=>MUjTRW5ITVJ?
MEG-01MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVnt[JRiUUN3ME2wMlAxODF{ODFOwG0>MUPTRW5ITVJ?
LAMA-84Mlm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnkTWM2OD1yLkCwNFE3PSEQvF2=MkjCV2FPT0WU
CGTH-W-1MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHDZ5NKUUN3ME2wMlAxOTZ7IN88US=>NHfUdndUSU6JRWK=
KASUMI-1NHzzfXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTBwMECyNVch|ryPMnqxV2FPT0WU
BE-13MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVf3Um9bUUN3ME2wMlAxOjV7IN88US=>MmPFV2FPT0WU
CTV-1MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMEC1NlEh|ryPNGHQZpFUSU6JRWK=
NKM-1NFHGU4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTBwMEC2OVUh|ryPNULadVVVW0GQR1XS
MONO-MAC-6MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzGTWM2OD1yLkCwPFM4KM7:TR?=MoqxV2FPT0WU
A204NULDXYY4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33EfWlEPTB;MD6wNVIyQCEQvF2=MmfOV2FPT0WU
GDM-1M1zpeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfSXWdKSzVyPUCuNFE5OzNizszNM4XPVHNCVkeHUh?=
AN3-CAM4\6dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTBwMEG4O|Mh|ryPNVTzS2p5W0GQR1XS
BL-70NGDaN2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMEKxPVkh|ryPNHr3UVNUSU6JRWK=
DaudiNHHRWm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvxXIhTUUN3ME2wMlAzPTN5IN88US=>MkPlV2FPT0WU
KU812NV25c4R5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDUTFNYUUN3ME2wMlAzQDR6IN88US=>MUDTRW5ITVJ?
KG-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPGTWM2OD1yLkCzNlk1KM7:TR?=MVHTRW5ITVJ?
DOHH-2MojHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTBwMES4NFMh|ryPMWrTRW5ITVJ?
HuO9M2HXWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3tTWM2OD1yLkC1OFQ5KM7:TR?=NGj3[oZUSU6JRWK=
EB2MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2[xZ2lEPTB;MD6wOVU4PiEQvF2=NETTUYFUSU6JRWK=
G-402NVfTXG5rT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\SSpFkUUN3ME2wMlA3OzRzIN88US=>MmHnV2FPT0WU
SU-DHL-1MkXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF\qXoxKSzVyPUCuNFY{PzlizszNM4P0fHNCVkeHUh?=
NCI-H719MlfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vZTGlEPTB;MD6wO|g5QCEQvF2=MVLTRW5ITVJ?
MLMAMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPlbHBKSzVyPUCuNFkxPiEQvF2=NISwSWVUSU6JRWK=
KM12M2e4emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTBwMEm3N|ch|ryPNYW2T5hCW0GQR1XS
SUP-T1NEL4[WtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGDjWFBKSzVyPUCuNFk6QDJizszNM160XnNCVkeHUh?=
MZ1-PCMljLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITJT2tKSzVyPUCuNVE{OzZizszNMXPTRW5ITVJ?
MFE-296M{TyWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXzJR|UxRTBwMUG4N|kh|ryPM2PSRXNCVkeHUh?=
ALL-PONGTZbI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPLbXhKSzVyPUCuNVI1PDNizszNNF3oOopUSU6JRWK=
GB-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXHPRoZmUUN3ME2wMlEzPTF{IN88US=>MUTTRW5ITVJ?
SIG-M5Mo\nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTBwMUOzO{DPxE1?MUDTRW5ITVJ?
P30-OHKNHfvb4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4ntSGlEPTB;MD6xOVY4OiEQvF2=MnzNV2FPT0WU
NCI-H716MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFvaOIhKSzVyPUCuNVYzPjZizszNNHfJNJVUSU6JRWK=
MPP-89M3roUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoO0TWM2OD1yLkG2PVM{KM7:TR?=M2K2cnNCVkeHUh?=
SF126MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\PTWM2OD1yLkG3NFY{KM7:TR?=MUTTRW5ITVJ?
CTB-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwMUezNVYh|ryPNVfrNZV7W0GQR1XS
CA46NVnqWXRKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTBwMUe0PFkh|ryPNILkR3BUSU6JRWK=
NCI-H520MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3Pq[GlEPTB;MD6xO|c{OiEQvF2=MnKyV2FPT0WU
CAL-85-1MojjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzYVINKSzVyPUCuNVc6OjdizszNM4\3WXNCVkeHUh?=
NCI-H2342MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4K3ZmlEPTB;MD6xPFU4PyEQvF2=M1nDUHNCVkeHUh?=
697NHTPT4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4f0Z2lEPTB;MD6xPFg4OSEQvF2=MlfiV2FPT0WU
NYM2i5Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHuR3BKSzVyPUCuNVkzQDdizszNMUPTRW5ITVJ?
T98GMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzp[JYzUUN3ME2wMlE6OzF6IN88US=>NXnHOI9yW0GQR1XS
NCI-H1703NVqxVFh7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\aOWlEPTB;MD6xPVYyPSEQvF2=NGPJNYRUSU6JRWK=
NCI-H2087MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX[xN2dNUUN3ME2wMlIxPDN7IN88US=>NXr1NoN{W0GQR1XS
PF-382MmHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTBwMkC4O|Mh|ryPMnnCV2FPT0WU
HCT-116MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;4TWM2OD1yLkKxNFY6KM7:TR?=M3jabHNCVkeHUh?=
CAKI-1NW\aZ3Z7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVfJR|UxRTBwMkG2OlYh|ryPM1;T[HNCVkeHUh?=
CCF-STTG1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHFTWM2OD1yLkKyOFc2KM7:TR?=M2HrOXNCVkeHUh?=
D-392MGMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfBfIpDUUN3ME2wMlI{OTd5IN88US=>NXvncZBnW0GQR1XS
RT-112MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTBwMkO3PVUh|ryPM37zbnNCVkeHUh?=
MES-SAMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTBwMkSxPFch|ryPMUDTRW5ITVJ?
LC-2-adNEnBWJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3L0NWlEPTB;MD6yOFI3PSEQvF2=M{n3PXNCVkeHUh?=
NOS-1MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVfzUlZGUUN3ME2wMlI1OzZ5IN88US=>M1nWWXNCVkeHUh?=
NALM-6MnXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHDXIRKSzVyPUCuNlU2PDNizszNMmLEV2FPT0WU
TE-15M{XN[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrvWFJOUUN3ME2wMlI3ODlzIN88US=>M2q3S3NCVkeHUh?=
786-0NIDEVpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2WyNWlEPTB;MD6yOlIzQCEQvF2=M3PhO3NCVkeHUh?=
IST-MES1Mn6xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MljYTWM2OD1yLkK2PFI6KM7:TR?=MnztV2FPT0WU
KYSE-180MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLLTWM2OD1yLkK2PFkyKM7:TR?=NGXsbG5USU6JRWK=
YTMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVH6c2M6UUN3ME2wMlI3QTd2IN88US=>M2DLVXNCVkeHUh?=
A427MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTBwMkeyOlQh|ryPMVnTRW5ITVJ?
KYSE-450M1;qbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{i4O2lEPTB;MD6yO|MzQSEQvF2=NFLDRnVUSU6JRWK=
HuH-7Ml\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIK0V3hKSzVyPUCuNlc4PjNizszNNF;IXmhUSU6JRWK=
CAS-1M2SxNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkftTWM2OD1yLkK4N|A{KM7:TR?=NWHRZXpTW0GQR1XS
KURAMOCHIM2fQXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NECxfHJKSzVyPUCuNlg1OTlizszNM4f0PHNCVkeHUh?=
ACHNNWDheHFvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDYNnJkUUN3ME2wMlI6OzJ|IN88US=>MlvVV2FPT0WU
HGC-27MlLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTBwMkmzOVMh|ryPM1HZW3NCVkeHUh?=
A172M2X6d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTBwMkm1O|ch|ryPNXP1OYdnW0GQR1XS
SNU-449NXL2TnZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVj4V2oyUUN3ME2wMlI6QTZ2IN88US=>MnXRV2FPT0WU
SW982NHT4R4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHP5RpBKSzVyPUCuNlk6PzhizszNMmDEV2FPT0WU
EFO-21Mm[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;kSWlEPTB;MD6zNFQyOSEQvF2=NGTSUHRUSU6JRWK=
NCI-H2030NEX0NodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDZXW1KSzVyPUCuN|EyPjRizszNNEDlUYtUSU6JRWK=
HT-144M3n2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTBwM{GyPEDPxE1?MmLUV2FPT0WU
MFE-280Mk\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGrPbFNKSzVyPUCuN|E1PTNizszNMl:yV2FPT0WU
SK-LU-1NY\sbW5KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTBwM{G0OlYh|ryPMYDTRW5ITVJ?
NCI-H2052M{nxS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{W2bWlEPTB;MD6zNVQ5PCEQvF2=MmC3V2FPT0WU
SK-HEP-1NWTF[|VqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXe4SnhJUUN3ME2wMlM{OzZ6IN88US=>MnPJV2FPT0WU
QIMR-WILNXy5T5d6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlv2TWM2OD1yLkOzOFI1KM7:TR?=MonDV2FPT0WU
A2780Mn7mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGSycppKSzVyPUCuN|Q{ODRizszNMVfTRW5ITVJ?
ACNM3n2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTBwM{S4O|Mh|ryPM{PLWnNCVkeHUh?=
BxPC-3MojjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjWRnpKSzVyPUCuN|Q6QDlizszNM3TieXNCVkeHUh?=
BCPAPM1zwNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPLUopbUUN3ME2wMlM3ODBzIN88US=>M1vyUXNCVkeHUh?=
HOP-62MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTBwM{[xNFYh|ryPNIPTXGNUSU6JRWK=
SW1710MlvmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLodmplUUN3ME2wMlM3PDV3IN88US=>NV;pZllQW0GQR1XS
OPM-2NFHwSVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PnPWlEPTB;MD6zOlQ4OyEQvF2=MUDTRW5ITVJ?
DBTRG-05MGMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF:2cJVKSzVyPUCuN|gxPTRizszNNYLIfGNvW0GQR1XS
SK-MEL-24Ml;ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{fSZmlEPTB;MD6zPVc6OSEQvF2=Ml3WV2FPT0WU
8305CM4XvZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVvJR|UxRTBwM{m3PVMh|ryPM4TqRXNCVkeHUh?=
OVCAR-4NXvYUXlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEfTdodKSzVyPUCuOFE2QDZizszNMWrTRW5ITVJ?
HLEMoOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3JdnFKSzVyPUCuOFE5PiEQvF2=NHXKPXVUSU6JRWK=
NCI-H747Mle1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[xRXROUUN3ME2wMlQzOTN5IN88US=>M3fsNXNCVkeHUh?=
SW780MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTBwNEKzOFYh|ryPMUHTRW5ITVJ?
KYSE-150Ml;FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWixfJBpUUN3ME2wMlQzPDF3IN88US=>NHrXWGJUSU6JRWK=
H4M{THTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PDNWlEPTB;MD60NlQ2OSEQvF2=M13odHNCVkeHUh?=
SW1088NHq3N4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX2yRXRkUUN3ME2wMlQ1OzlizszNMU\TRW5ITVJ?
SF268MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlrYTWM2OD1yLkS0PFYh|ryPMYjTRW5ITVJ?
RT4NXjkTpNiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTWVoI6UUN3ME2wMlQ2OTFzIN88US=>MUfTRW5ITVJ?
NCI-H522MlPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\v[3ZNUUN3ME2wMlQ2OjdizszNMXXTRW5ITVJ?
LCLC-97TM1M2TuOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPHWZpKSzVyPUCuOFYyQTVizszNNUHPXpFUW0GQR1XS
CAL-39M2rv[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoG0TWM2OD1yLkS2OVE6KM7:TR?=MXnTRW5ITVJ?
CAL-120M4nzdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlmwTWM2OD1yLkS3OlQ{KM7:TR?=MnGwV2FPT0WU
ESS-1NYj5clRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HqdGlEPTB;MD60O|gzOSEQvF2=NX\ORmg6W0GQR1XS
KARPAS-45NGG3d|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTBwNEi5N|Mh|ryPNXjVR|g2W0GQR1XS
DU-4475MmjSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPWXGZ[UUN3ME2wMlQ6PTFzIN88US=>NHnQeYlUSU6JRWK=
VMRC-RCZMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HjWWlEPTB;MD60PVkxPCEQvF2=NF3oV2pUSU6JRWK=
HOSNY\jNoZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDZcVJGUUN3ME2wMlUxOzZ3IN88US=>NGTiTYZUSU6JRWK=
MOLT-16MnHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\kS2lEPTB;MD61NVgxQCEQvF2=M2rIbXNCVkeHUh?=
RPMI-6666NULBfGZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWj2PY9UUUN3ME2wMlUzOTN3IN88US=>MXLTRW5ITVJ?
K052NFHwb4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17vfWlEPTB;MD61NlE1KM7:TR?=NV;ITG1NW0GQR1XS
EHEBNVHVZpNIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TwfWlEPTB;MD61NlE5OiEQvF2=MYHTRW5ITVJ?
MFH-inoM1TLSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLlU2JKSzVyPUCuOVI{PTFizszNNV;aelYzW0GQR1XS
A4-FukMmfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXLJR|UxRTBwNUK1Nlgh|ryPMoDGV2FPT0WU
SW1417NE\EbJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHqzeGNKSzVyPUCuOVI4QDFizszNNHv2VGNUSU6JRWK=
DoTc2-4510MnnJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLIW2dRUUN3ME2wMlU1QTV6IN88US=>MnvCV2FPT0WU
TE-12Mof0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfDTWM2OD1yLkW1O|M2KM7:TR?=MW\TRW5ITVJ?
8-MG-BAM4rOTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PLdmlEPTB;MD61OlA2PiEQvF2=M{jPSnNCVkeHUh?=
ECC12NVrRd|hpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwNU[1OVgh|ryPMWjTRW5ITVJ?
CHL-1NVzlNVliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTBwNUe0OlMh|ryPM363OnNCVkeHUh?=
LCLC-103HMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTBwNUizOFQh|ryPNV7rVodrW0GQR1XS
OS-RC-2NGHzSZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLDTWM2OD1yLkW4N|c6KM7:TR?=MWXTRW5ITVJ?
RO82-W-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTBwNUm2NVUh|ryPMnLCV2FPT0WU
A3-KAWNXnPfGYzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXZWmdKSzVyPUCuOlE1PjdizszNNFHNRW1USU6JRWK=
NCCITMnnWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnoWYVKSzVyPUCuOlE4OTVizszNNHS2NmRUSU6JRWK=
IST-SL2NWLzNYR2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLITWM2OD1yLk[yOVIzKM7:TR?=NVvNPHF2W0GQR1XS
GI-ME-NNWLZR|BuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;nPYxKSzVyPUCuOlMxPjlizszNMVTTRW5ITVJ?
ES6M2nncGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHYTWM2OD1yLk[zNlk2KM7:TR?=NX6weoM1W0GQR1XS
BL-41MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nuXGlEPTB;MD62N|M2OiEQvF2=MWjTRW5ITVJ?
Ca-SkiNEHFVWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjZTWM2OD1yLk[0PFEh|ryPNHS4SVRUSU6JRWK=
HOP-92NYTZXJFLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LvfWlEPTB;MD62OVY4OiEQvF2=NXPke|RNW0GQR1XS
SK-LMS-1NELie21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfOTWM2OD1yLk[2OFch|ryPNX72RWZyW0GQR1XS
EW-13MmjMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17GT2lEPTB;MD62Olc4QSEQvF2=NFn2PJZUSU6JRWK=
647-VNHjZOnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFrOSZdKSzVyPUCuOlgyPDhizszNNY\zWWVVW0GQR1XS
JiyoyeP-2003NGX3cldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HkOWlEPTB;MD62PVc{QCEQvF2=NUX5c5N3W0GQR1XS
WSU-NHLNXXWWJVQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwN{C4PFch|ryPM3fPfXNCVkeHUh?=
U-698-MMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml3BTWM2OD1yLkexNFY{KM7:TR?=MX;TRW5ITVJ?
HC-1M1P5Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYD6[Y1zUUN3ME2wMlczPDB3IN88US=>MVHTRW5ITVJ?
8505CNHHiboVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PaPWlEPTB;MD63Nlc1OSEQvF2=NV3CTnJLW0GQR1XS
HUTU-80MmfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfkTWM2OD1yLkezN|Q6KM7:TR?=MUfTRW5ITVJ?
LB1047-RCCMl7aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX:xWZA3UUN3ME2wMlc{PTN6IN88US=>NVPyUpRCW0GQR1XS
GAMGMmfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3rpbWlEPTB;MD63N|Y2OyEQvF2=M2jQfXNCVkeHUh?=
CAL-12TNFv2e2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjXO3JKUUN3ME2wMlc{QDd5IN88US=>MXnTRW5ITVJ?
NCI-SNU-1M3nMPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fnfWlEPTB;MD63O|I4QCEQvF2=M2L2WnNCVkeHUh?=
HTC-C3NUnVc2RpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYT2fppuUUN3ME2wMlc4PDVzIN88US=>NXnnb25wW0GQR1XS
HPAF-IIMnHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jMV2lEPTB;MD63O|UxOSEQvF2=MlvKV2FPT0WU
KGNNX;2O|A{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHrQZmFKSzVyPUCuO|gxQDFizszNNF3RN3BUSU6JRWK=
EFO-27MkezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTBwN{i3N|Mh|ryPMoTsV2FPT0WU
MEL-HONHn5NplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn32TWM2OD1yLke5OFQ6KM7:TR?=MWfTRW5ITVJ?
KYSE-270MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nEWWlEPTB;MD64NFUzQSEQvF2=NHHlSGNUSU6JRWK=
NCI-H1755NX;wT|lFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2fTU2lEPTB;MD64NFcyPCEQvF2=MXjTRW5ITVJ?
MFM-223MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTBwOEG0NFch|ryPM3[y[XNCVkeHUh?=
G-361M{THVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDyeZJHUUN3ME2wMlgyQDl5IN88US=>NFvwRo5USU6JRWK=
ETK-1NXfJc|hDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13hTGlEPTB;MD64NlQ1OSEQvF2=MnzQV2FPT0WU
LU-99ANHvvZWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTBwOES3NFEh|ryPNYf4eXhlW0GQR1XS
IST-MEL1M2jNcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHVRm9KSzVyPUCuPFU4OzJizszNMkTPV2FPT0WU
L-540MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTBwOEW4NFEh|ryPMVXTRW5ITVJ?
U-2-OSNVTRXnVNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DWVWlEPTB;MD64OVg1PiEQvF2=M3[x[nNCVkeHUh?=
HT-1376NUTC[45[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTsb4VmUUN3ME2wMlg3ODVzIN88US=>NVntXmpLW0GQR1XS
COLO-680NNGD4dXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXWdYNKSzVyPUCuPFc6OzNizszNM17WeHNCVkeHUh?=
NCI-H1581MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkP5TWM2OD1yLki5Nlk4KM7:TR?=NFLsSY9USU6JRWK=
HuCCT1NX;0NYNUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TxNGlEPTB;MD64PVU1QCEQvF2=MWfTRW5ITVJ?
BB30-HNCMlnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4DxW2lEPTB;MD65NlQ3QSEQvF2=NX;QXZNYW0GQR1XS
NCI-H2347MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH\wN49KSzVyPUCuPVMzQTJizszNMnnOV2FPT0WU
G-401NIjlbJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYr6fFN6UUN3ME2wMlk{Pjl3IN88US=>NIn4fGlUSU6JRWK=
NCI-H358MkfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1fOe2lEPTB;MD65OVAyPCEQvF2=MoO5V2FPT0WU
HCC1395MoK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXLxVmFFUUN3ME2wMlk2PDZzIN88US=>NFLvd5NUSU6JRWK=
J82NFjY[FNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTBwOUW1OFMh|ryPNEHveY1USU6JRWK=
KE-37NILiVnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3uzNmlEPTB;MD65OlM5PyEQvF2=M37sUnNCVkeHUh?=
NOMO-1Mlm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnxZW9KSzVyPUCuPVY2PjRizszNM1r4bXNCVkeHUh?=
ML-2MmDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1m2OGlEPTB;MD65PVc2KM7:TR?=Mm\pV2FPT0WU
SW872NXrXUY9kT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mli4TWM2OD1yLkm5O|c2KM7:TR?=NVHKPIp2W0GQR1XS
KYSE-520MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1ezfWlEPTB;MT6wNFQ6PCEQvF2=NVXCeoxiW0GQR1XS
HL-60NFXUXXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIjqWXFKSzVyPUGuNFA6PyEQvF2=M1nLdXNCVkeHUh?=
HDLM-2M3nSZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVjGeY1DUUN3ME2xMlAyOjV{IN88US=>NIHNUWFUSU6JRWK=
MIA-PaCa-2MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX;ueZZ3UUN3ME2xMlAyOzd3IN88US=>MlO4V2FPT0WU
TCCSUPNGDDTpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HJO2lEPTB;MT6wNVc{OiEQvF2=NV\hUnBtW0GQR1XS
SH-4MlzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1vyVWlEPTB;MT6wNlI1PCEQvF2=Ml7VV2FPT0WU
MG-63NGn2SIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTFwMEK2NVYh|ryPM{HZOHNCVkeHUh?=
NB6M2Xrfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3sdVFKSzVyPUGuNFMyODlizszNMYnTRW5ITVJ?
CAL-54MmC3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHPYbnhKSzVyPUGuNFM6PTlizszNMX\TRW5ITVJ?
DU-145MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTFwMEiwO|Mh|ryPMlPUV2FPT0WU
HCE-4MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzIcWg2UUN3ME2xMlA6Ojh4IN88US=>NXXvbZRSW0GQR1XS
U-266NVzS[IhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvpTWM2OD1zLkC5OlM{KM7:TR?=NYL1Z3NpW0GQR1XS
HT-1197MmPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvRVoxKSzVyPUGuNVE1OzhizszNMXjTRW5ITVJ?
EW-1M2fUc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYmxdW9uUUN3ME2xMlE1OTJ6IN88US=>MV;TRW5ITVJ?
MHH-NB-11M1jEdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXpclY{UUN3ME2xMlE2OzZ6IN88US=>MWHTRW5ITVJ?
NCI-H2405NWPpVGM5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF:2[3NKSzVyPUGuNVYyPiEQvF2=NWjIbXc5W0GQR1XS
COLO-668NVnsVIF4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnr2TWM2OD1zLkG2OFkh|ryPM1;jVnNCVkeHUh?=
IMR-5MlK1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml\RTWM2OD1zLkG2PVM3KM7:TR?=MmS5V2FPT0WU
ARH-77NHrIcIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTFwMkK5NlQh|ryPM1T5eHNCVkeHUh?=
BHT-101Mn3pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXVXVhjUUN3ME2xMlI{PDlizszNM{T1bHNCVkeHUh?=
SCC-25MkPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLPWpFKSzVyPUGuNlM2OzZizszNNXnaZnV{W0GQR1XS
NTERA-S-cl-D1NHjDWZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1H0bmlEPTB;MT6yOFM1PiEQvF2=NWG5bWJIW0GQR1XS
MKN28MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DVSmlEPTB;MT6yOVY{PiEQvF2=MoLuV2FPT0WU
KS-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3i4RmlEPTB;MT6yPFI3QSEQvF2=MlzRV2FPT0WU
NCI-H1734MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTFwMki5NVMh|ryPMlW2V2FPT0WU
ES7MmLrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkK5TWM2OD1zLkK5OVQzKM7:TR?=NV24Xok1W0GQR1XS
NCI-H838MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIq1eWxKSzVyPUGuN|A3OTVizszNM4fZfHNCVkeHUh?=
HEC-1M1fXPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlK0TWM2OD1zLkOzO|U2KM7:TR?=NYXvVYY2W0GQR1XS
ME-180NF;jVo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rTVGlEPTB;MT6zO|k6OyEQvF2=NUHHOmFGW0GQR1XS
MMAC-SFMn:yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4[yNWlEPTB;MT6zPVU6PSEQvF2=MVvTRW5ITVJ?
IA-LMMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTFwNEC5NVQh|ryPNGfhTHZUSU6JRWK=
MN-60Ml\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmruTWM2OD1zLkSzNVE1KM7:TR?=NETmUpBUSU6JRWK=
SIMAMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4T6emlEPTB;MT60PFY5PyEQvF2=NWHmeFltW0GQR1XS
NCI-H1770NUmwZoxyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2D3TmlEPTB;MT61NlA2PCEQvF2=M1fkPXNCVkeHUh?=
ONS-76MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3LXVGlEPTB;MT61NlMyOSEQvF2=NXjWd5M1W0GQR1XS
LB771-HNCM2TSe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvzTWM2OD1zLkWzPVA3KM7:TR?=NYXkUW1EW0GQR1XS
SW48M{LLcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTFwNUSyOFMh|ryPMl7hV2FPT0WU
KYSE-140MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTFwNUW3OFEh|ryPNE[yU|NUSU6JRWK=
SW626NGPSbmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7wTWM2OD1zLkW4NVYh|ryPM3Xj[XNCVkeHUh?=
MC-CARNU\Fcm5tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTFwNUi2OlMh|ryPMULTRW5ITVJ?
D-336MGNGK4cFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYC3SWl2UUN3ME2xMlYzQTRizszNM1rsbnNCVkeHUh?=
SK-MEL-3NGHofFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmX3TWM2OD1zLk[zPVAzKM7:TR?=NF7uWGhUSU6JRWK=
MHH-PREB-1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2fyW2lEPTB;MT62OFQ4OyEQvF2=Moe5V2FPT0WU
Calu-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjBdYhJUUN3ME2xMlY2Ozh4IN88US=>MWXTRW5ITVJ?
HCC1806NF;SZ4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrx[pJTUUN3ME2xMlY3PjFzIN88US=>NIS3c|lUSU6JRWK=
A101DNGDtW4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnCWZRKSzVyPUGuOlY4QDFizszNMV7TRW5ITVJ?
A704M2nGOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1X4e2lEPTB;MT62PFMyOSEQvF2=M1L1T3NCVkeHUh?=
LB831-BLCMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFvDTo1KSzVyPUGuOlk5PTRizszNMVPTRW5ITVJ?
RL95-2Mmi4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHS3SIJKSzVyPUGuO|E1PjNizszNMmfrV2FPT0WU
RPMI-2650Mlf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3Hvc2lEPTB;MT63NlcyQSEQvF2=M4fCZ3NCVkeHUh?=
NH-12NGH3UZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTFwN{O0Nlch|ryPNUXwZ4hYW0GQR1XS
AGSNEX0e5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTFwN{[zOVgh|ryPM1Thc3NCVkeHUh?=
NEC8NXHOS2Q{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3;6W2lEPTB;MT63PFk6PSEQvF2=NGjMfXlUSU6JRWK=
NCI-H2009NIPNSnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jMVGlEPTB;MT63PVczOSEQvF2=NGjCfHdUSU6JRWK=
A498MkLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjRR4lnUUN3ME2xMlgyOjh{IN88US=>NYD4UnVqW0GQR1XS
NCI-H810NXTHUlljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmqwTWM2OD1zLkixOlA3KM7:TR?=MUTTRW5ITVJ?
SK-NEP-1M3zsPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\pTWM2OD1zLkizO|Y4KM7:TR?=NIOxUYlUSU6JRWK=
D-542MGNV6wbYx7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XEdGlEPTB;MT64OVg2OSEQvF2=NHr6Z4pUSU6JRWK=
KNS-42NWnoO5BYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mof1TWM2OD1zLki2NlY3KM7:TR?=NH\YWplUSU6JRWK=
NCI-H2452MkPFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4Hpc2lEPTB;MT64PVA4PCEQvF2=MWLTRW5ITVJ?
SK-MEL-2M1T0bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3EUFRKUUN3ME2xMlkxOjdzIN88US=>MVTTRW5ITVJ?
OVCAR-5NI[1R3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV3VOmRzUUN3ME2xMlkxPjd3IN88US=>NVW1dXRwW0GQR1XS
SNG-MNGPYb4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjYTWM2OD1zLkm1PFU5KM7:TR?=NHXKZZFUSU6JRWK=
A673MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHqdnpKSzVyPUGuPVc2OTZizszNNVf0Tmd{W0GQR1XS
L-428NHPM[3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrLTWM2OD1zLkm5NVc6KM7:TR?=MWjTRW5ITVJ?
KM-H2MlL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTJwMEGwPUDPxE1?NGjkbXpUSU6JRWK=
MC-IXCMoj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\zS2NOUUN3ME2yMlAzOjd|IN88US=>NW\IdolLW0GQR1XS
COLO-678MlHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTJwMESyNFch|ryPM1fFVXNCVkeHUh?=
MEL-JUSOMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTJwMEe4OVEh|ryPMknQV2FPT0WU
HCC38MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFvqcHdKSzVyPUKuNFg1OzNizszNNWP2UW5{W0GQR1XS
UACC-62NFm0U2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn21TWM2OD1{LkC4PFU2KM7:TR?=NIfqWYxUSU6JRWK=
OAW-42MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfPfVlKSzVyPUKuNFk4OTFizszNMk\2V2FPT0WU
LB996-RCCM4fhR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTJwMUO4NVch|ryPMoTtV2FPT0WU
COR-L105M3zQW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTJwMU[zO|Mh|ryPMYjTRW5ITVJ?
RCC10RGBMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVnITZZzUUN3ME2yMlE5PTd4IN88US=>MVvTRW5ITVJ?
A431NV3NfmtFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIH1Z2FKSzVyPUKuNVkxOTlizszNNYrNZ2NDW0GQR1XS
NCI-H292MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInrdHZKSzVyPUKuNlM6PTFizszNM3[0fHNCVkeHUh?=
SK-UT-1NXPidoZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDWflVJUUN3ME2yMlM{OTh2IN88US=>MlHQV2FPT0WU
PANC-08-13MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4H0XGlEPTB;Mj6zN|I{PSEQvF2=MnLhV2FPT0WU
ST486MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17COmlEPTB;Mj60NVA1QCEQvF2=MXjTRW5ITVJ?
SJSA-1NHHLdIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGntTZFKSzVyPUKuOFEzPzFizszNMXXTRW5ITVJ?
RKOMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1X2bGlEPTB;Mj60NlAzQSEQvF2=MWjTRW5ITVJ?
NCI-H1793NUT2cVdlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTJwNESwNlkh|ryPMlXUV2FPT0WU
639-VMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETnbHZKSzVyPUKuOFU{QDJizszNMWLTRW5ITVJ?
ES3MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV3JR|UxRTJwNEm3N|ch|ryPNV30RldNW0GQR1XS
NCI-H1792NHv3S4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYnJR|UxRTJwNU[4NlYh|ryPMn\4V2FPT0WU
NCI-H1651MkHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TGcmlEPTB;Mj61PFIyKM7:TR?=NYXON4JLW0GQR1XS
SN12CMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVjr[mtsUUN3ME2yMlU5PDh5IN88US=>M1fyXnNCVkeHUh?=
COLO-679M3zlOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYHJR|UxRTJwNUi2NFUh|ryPMn7PV2FPT0WU
U-118-MGNITpNotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkn6TWM2OD1{LkW4PFczKM7:TR?=MnOzV2FPT0WU
Ramos-2G6-4C10NYDSeVAzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVfsZXBQUUN3ME2yMlY1QDB5IN88US=>NEjM[mVUSU6JRWK=
HCT-15NGjJdXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzBWoxKSzVyPUKuOlg4QTJizszNNUjPNnVvW0GQR1XS
MDA-MB-157NH73SHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnf2TWM2OD1{LkewO|Q4KM7:TR?=NXLaVGdSW0GQR1XS
K5MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELye2pKSzVyPUKuO|E5PDVizszNNYD6NGxvW0GQR1XS
MKN45NF7CZXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTJwN{OzOlYh|ryPNF\DUWhUSU6JRWK=
DMS-273M{eyRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUD3cHN7UUN3ME2yMlc2PjN{IN88US=>NHLOSohUSU6JRWK=
C8166M1rzdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7tTWM2OD1{Lke4OVE{KM7:TR?=M4GxcXNCVkeHUh?=
Calu-3MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjO[lBKUUN3ME2yMlc5QTZ7IN88US=>M1rmVXNCVkeHUh?=
SNB75NWr6[mlST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\pVYdKSzVyPUKuPFg2OzVizszNNGPPR|RUSU6JRWK=
BFTC-905NEHod3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfZdlJKSzVyPUKuPVAyQTFizszNMWfTRW5ITVJ?
C-4-IIMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{X6SWlEPTB;Mj65NVM2OyEQvF2=MXPTRW5ITVJ?
MS-1NWjLUmhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTJwOU[3Olkh|ryPMX7TRW5ITVJ?
A375MmrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXLVOlR1UUN3ME2zMlA5OTh2IN88US=>MWnTRW5ITVJ?
KYSE-70M{C1bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfDcnc4UUN3ME2zMlA5QDh{IN88US=>MkTaV2FPT0WU
KYSE-510MoK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPlNYJ7UUN3ME2zMlExQTl3IN88US=>NFj4NmxUSU6JRWK=
LN-405NXjZZY5WT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3vQdmlEPTB;Mz6xN|UyQCEQvF2=M{jhVHNCVkeHUh?=
BOKUNWXSc|JKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1noVmlEPTB;Mz6xOFI2PiEQvF2=MoHFV2FPT0WU
TE-10NXvMOFdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPFTWM2OD1|LkG3N|YzKM7:TR?=M3HyS3NCVkeHUh?=
MKN1NILGUG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTNwMUi0PFMh|ryPNFL5e2hUSU6JRWK=
M059JNFK1fmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk[xTWM2OD1|LkKwNVc{KM7:TR?=M37xfnNCVkeHUh?=
GOTOMnLTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXrHRVZ{UUN3ME2zMlIzODN7IN88US=>M2S4PXNCVkeHUh?=
DK-MGMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTNwMkW5O|Yh|ryPNFvXNFZUSU6JRWK=
NCI-H727MnzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2PrWGlEPTB;Mz6yOlU5KM7:TR?=MWTTRW5ITVJ?
NB12MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXQTWM2OD1|LkOzNlI1KM7:TR?=M1H2e3NCVkeHUh?=
DOKNXXJW3JQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\BeoFCUUN3ME2zMlM3OTh4IN88US=>M3PubnNCVkeHUh?=
KYSE-410NWHwWWp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIDhOWlKSzVyPUOuN|YzQDdizszNM1e1R3NCVkeHUh?=
AM-38MnntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1v0b2lEPTB;Mz6zPFA2OSEQvF2=MYjTRW5ITVJ?
GR-STNFfsSpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmqxTWM2OD1|LkS1O|MzKM7:TR?=NWPZcGsxW0GQR1XS
D-247MGMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLUTWM2OD1|LkS4NlY{KM7:TR?=M4HVWnNCVkeHUh?=
TE-8Mn25S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH[wfIlKSzVyPUOuOFk{OzNizszNMY\TRW5ITVJ?
LS-411NNX20[WRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;LTWM2OD1|LkS5OlkzKM7:TR?=MXPTRW5ITVJ?
SK-MES-1NVr2[mtQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XuNmlEPTB;Mz61OlQ{OyEQvF2=NWLxRZdJW0GQR1XS
SF295MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTNwNkG1OVIh|ryPMn76V2FPT0WU
SK-MEL-30MnriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVy4S2JqUUN3ME2zMlY2QTJzIN88US=>NYrCZoV2W0GQR1XS
LB2241-RCCMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTNwNk[yOkDPxE1?NVjhNmtPW0GQR1XS
PC-14NFP0e4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXoS3FKSzVyPUOuOlY1OzdizszNNHG0[XpUSU6JRWK=
EW-7MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTNwNke2PVMh|ryPNIfIPZBUSU6JRWK=
NMC-G1NELJZZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLJTWM2OD1|LkexPFM4KM7:TR?=NFzhOHZUSU6JRWK=
TE-441-TNFvrXHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjBXYNKSzVyPUOuO|MxOjhizszNNE\GRW1USU6JRWK=
NCI-H1618MlrVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fzc2lEPTB;Mz64NVg4PSEQvF2=M2W4ZXNCVkeHUh?=
PANC-03-27NWPPeZVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHQZ2FLUUN3ME2zMlgyQTF4IN88US=>NEHXZWVUSU6JRWK=
NCI-H2228MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W1U2lEPTB;Mz64N|EzPiEQvF2=MofYV2FPT0WU
CAPAN-1NEfMSYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnL4TWM2OD1|Lki3NFA6KM7:TR?=NH\XcotUSU6JRWK=
KLEM3TwVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTNwOUC2O{DPxE1?MXjTRW5ITVJ?
BeckerNEPqUnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLTUZhKSzVyPUOuPVI5PDlizszNMoT1V2FPT0WU
SK-PN-DWMm\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLJTWM2OD12LkC3PVc1KM7:TR?=MV7TRW5ITVJ?
Hs-578-TMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\3RmlEPTB;ND6wPFMxPiEQvF2=NEjURoJUSU6JRWK=
RS4-11NYrEUm9DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHhbJd3UUN3ME20MlEyOjV3IN88US=>MnrPV2FPT0WU
D-502MGMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\JRY51UUN3ME20MlE3QTl5IN88US=>MkPDV2FPT0WU
GI-1MkjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYHx[5VFUUN3ME20MlI5Ojl7IN88US=>Mlq1V2FPT0WU
NCI-H209Ml\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn3xTWM2OD12LkOzO|gh|ryPNEnjSXhUSU6JRWK=
SK-OV-3M1zoZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NES3PI5KSzVyPUSuOFgyPDlizszNMWnTRW5ITVJ?
LOUCYMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGS3TJVKSzVyPUSuOFg1OzJizszNNIDVNHhUSU6JRWK=
NCI-H69M2HORmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYHJR|UxRTRwNUG3PVMh|ryPM{LMNnNCVkeHUh?=
SCC-9MnXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUjrRlZmUUN3ME20MlU{OTd{IN88US=>NUX3SodjW0GQR1XS
NCI-H526MmH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1HQXWlEPTB;ND61PVI6OyEQvF2=MlXsV2FPT0WU
NCI-H2170Mn;US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEXJb|dKSzVyPUSuOlY4PzFizszNNXGzWZZxW0GQR1XS
SRNGD3fmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlj1TWM2OD12LkewNFQ5KM7:TR?=NWfMOVd[W0GQR1XS
CMKMnPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILRdYNKSzVyPUSuO|IyODFizszNM3XDVXNCVkeHUh?=
COLO-829MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXvTWM2OD12Lke3NFQ{KM7:TR?=MVvTRW5ITVJ?
HuO-3N1NYTlRWgxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LNSmlEPTB;ND64N|I5OSEQvF2=NWrySohDW0GQR1XS
5637M1f5R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrodZJKSzVyPUSuPVA1QDdizszNNHjPZmNUSU6JRWK=
A253NGnWZoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELyb21KSzVyPUSuPVc4ODhizszNNEDIU21USU6JRWK=
NB10MmCyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDl[G5qUUN3ME21MlA4PDl5IN88US=>MWTTRW5ITVJ?
SF539NEGzNJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fjV2lEPTB;NT6wPVk2QSEQvF2=MXXTRW5ITVJ?
HAL-01MnjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTVwMUS2OFUh|ryPMUnTRW5ITVJ?
MHH-ES-1Mkn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3i2XmlEPTB;NT6xOlkzPSEQvF2=M4XRPHNCVkeHUh?=
DELMlTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTVwMke1PFIh|ryPM2TlTHNCVkeHUh?=
NCI-H1299NF\3VXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jTfmlEPTB;NT6zOVAxPyEQvF2=MljtV2FPT0WU
ChaGo-K-1M3;ieGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHJTWM2OD13LkO1NVA4KM7:TR?=MmjCV2FPT0WU
HMV-IINFGwNnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjUTWM2OD13LkO5OFMh|ryPNIDiO4lUSU6JRWK=
NB69M1TMeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXqTWM2OD13LkO5OlMyKM7:TR?=MnjqV2FPT0WU
NCI-H1882NFnsOW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTVwNEOzOlQh|ryPNUDRPGttW0GQR1XS
SNU-475MoDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTVwNEexO|Eh|ryPMYLTRW5ITVJ?
RXF393Mly1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmP3TWM2OD13LkS4OFk1KM7:TR?=MVHTRW5ITVJ?
CAL-51MnHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\XTWM2OD13Lk[yPFU{KM7:TR?=MYrTRW5ITVJ?
SW1573MlrqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILFfHFKSzVyPUWuOlM2OzRizszNM{HYSHNCVkeHUh?=
GCTNInpOmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIjwfm9KSzVyPUWuO|U6OjlizszNMmPlV2FPT0WU
COR-L88NVXaV|Z2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHBTWM2OD13Lke2PFQ3KM7:TR?=MV;TRW5ITVJ?
MDA-MB-134-VINVe1SIFGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2npe2lEPTB;NT64O|U{PiEQvF2=NWrpSo05W0GQR1XS
NB5NEXzdldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPkT5FKSzVyPUWuPVI1PCEQvF2=NXztVYx3W0GQR1XS
GMS-10NYrqUVllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2m5XGlEPTB;NT65Olg3OSEQvF2=M2Pje3NCVkeHUh?=
CHP-212MmSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPuTWM2OD14LkS4NlY4KM7:TR?=MnXHV2FPT0WU
TE-11MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXkTWM2OD14LkW1NVgzKM7:TR?=MonsV2FPT0WU
SW962MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HNVWlEPTB;Nj62OVc4PCEQvF2=Mn[wV2FPT0WU
MZ2-MELMoTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHRdpBvUUN3ME22MlgzODFzIN88US=>NUP6eoZyW0GQR1XS
C-33-ANIDnTlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\YUZRKSzVyPU[uPVE3QDhizszNMlfRV2FPT0WU
IGR-1Moq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVn4VnFXUUN3ME22Mlk4QDJ4IN88US=>MYPTRW5ITVJ?
MOLT-4NWTPZmhoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHLWG5KSzVyPUeuNVU1ODZizszNNUPlWoVEW0GQR1XS
NCI-H1650MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLsfXpQUUN3ME23MlI4ODR4IN88US=>MUfTRW5ITVJ?
AsPC-1NFjLcFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTdwMki2NFUh|ryPNGj1d5pUSU6JRWK=
SNU-C2BMnrvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3ObopIUUN3ME23MlI6PTdzIN88US=>MoPXV2FPT0WU
MKN7NY[1[XQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHsTWM2OD15LkO3NlM2KM7:TR?=NHz6UFBUSU6JRWK=
SW620Mn;ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVnoXGZ1UUN3ME23MlM5OjB3IN88US=>NVjCXndbW0GQR1XS
SK-MEL-28NVXrUpJQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfxR4lKSzVyPUeuOFA4QThizszNNWjNS2pJW0GQR1XS
TE-6M2fLbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTdwNES5NFgh|ryPNFXjUJpUSU6JRWK=
D-263MGNF;mdopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXNd4lKSzVyPUeuOFU4PjJizszNM4fxU3NCVkeHUh?=
NCI-H1355MlXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF[1T5lKSzVyPUeuO|cxOjlizszNNELEbWlUSU6JRWK=
DSH1NEW0eYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1ftemlEPTB;Nz63PVc3OiEQvF2=M3f1OHNCVkeHUh?=
NCI-H460NX3aSJFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\GVWZtUUN3ME24MlAxPjl2IN88US=>NGTYeohUSU6JRWK=
NCI-H1563NID6dVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7NTWM2OD16LkC3OVA5KM7:TR?=Mo\1V2FPT0WU
SW948NIfWWnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUT2[VczUUN3ME24MlExPzR2IN88US=>M33KTnNCVkeHUh?=
LK-2MoDGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XMRmlEPTB;OD6xNlg{OyEQvF2=M3zYcXNCVkeHUh?=
HT-1080NY\KSG1PT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HwN2lEPTB;OD6xN|E4PSEQvF2=M3PlVHNCVkeHUh?=
NCI-H441M{jMU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRThwMUmzJO69VQ>?M2rZOXNCVkeHUh?=
HSC-4Mof2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vZSmlEPTB;OD6yPFczKM7:TR?=NV;wO4NsW0GQR1XS
LXF-289NXvySmZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4T0b2lEPTB;OD6zOVk1OyEQvF2=NYjaWY8yW0GQR1XS
MRK-nu-1NYnwNGR2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLsTWM2OD16LkO2N|A1KM7:TR?=M3vORXNCVkeHUh?=
no-11NFvMbmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknlTWM2OD16LkS3NVM{KM7:TR?=MXnTRW5ITVJ?
SNU-387MmrIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRThwNkOyOFYh|ryPNIryNYJUSU6JRWK=
Detroit562NXnS[29yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRThwN{W0OVUh|ryPM4q3V3NCVkeHUh?=
SW954M3nLOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlzJTWM2OD16Lke2PFMzKM7:TR?=NWPicWxxW0GQR1XS
P12-ICHIKAWANHjmXHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXYRphKSzVyPUiuO|g6PCEQvF2=NUK0e4I6W0GQR1XS
TE-9NHTiPZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoroTWM2OD16LkixNFYzKM7:TR?=NFu1SJpUSU6JRWK=
NB13Mne0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRThwOEO3PVYh|ryPMkPFV2FPT0WU
BPH-1NHvyXYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE[1UVBKSzVyPUiuPFUxQDFizszNMUTTRW5ITVJ?
KMOE-2MlHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2HkcGlEPTB;OD64O|g6OiEQvF2=Ml:0V2FPT0WU
RPMI-8402MlToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRThwOEm5NlYh|ryPNULiOFAxW0GQR1XS
OVCAR-3NYHBPIUzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHL2W41KSzVyPUiuPVc4OzJizszNMXPTRW5ITVJ?
NCI-H2196MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRThwOUi2NFYh|ryPNELTd|JUSU6JRWK=
MZ7-melNEjHbXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2frcWlEPTB;OT6wN|Q3KM7:TR?=MWrTRW5ITVJ?
GP5dMnHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTlwME[zNVMh|ryPMnr2V2FPT0WU
NCI-N87NEXIW4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLuTWM2OD17LkS0O|MyKM7:TR?=MnPBV2FPT0WU
EW-16MnzLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGiwVHBKSzVyPUmuOFQ5PDhizszNMmXSV2FPT0WU
Calu-6NXXmRoxUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\rTWM2OD17LkS5O|A{KM7:TR?=MULTRW5ITVJ?
LC4-1MlrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTlwNkK1O{DPxE1?MnHFV2FPT0WU
CCRF-CEMNFH0bZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfwTWM2OD17Lk[4O|Y3KM7:TR?=M4jNNXNCVkeHUh?=
BC-1NUPGRoRjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTlwN{i5PUDPxE1?M4XKfXNCVkeHUh?=
NCI-SNU-16NXX2W49oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTlwN{m0PVUh|ryPM2Dxe3NCVkeHUh?=
NCI-H28MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV3JR|UxRTlwOES5N|Mh|ryPNEfzeY9USU6JRWK=
SBC-1M1zsR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1X4d2lEPTB;MUCuNFczKM7:TR?=NGLpNnNUSU6JRWK=
TURNX\1UoZtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3Cc|lWUUN3ME2xNE4yPjV5IN88US=>MlPoV2FPT0WU
MDA-MB-231MnTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTFyLkKxNVQh|ryPM2XNeXNCVkeHUh?=
C3AM2n0WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrPT|lDUUN3ME2xNE4{OTd7IN88US=>NUfsOG9DW0GQR1XS
SW1990M2nqOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\PbIJKSzVyPUGwMlMzQCEQvF2=MlHPV2FPT0WU
NCI-H1993MnPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfQSndKUUN3ME2xNE42Pjl|IN88US=>NXHSfXl6W0GQR1XS
SK-CO-1NFLiblJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnvN2g2UUN3ME2xNE44PzdizszNMlfmV2FPT0WU
OAW-28M2PC[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTFyLkm4PFgh|ryPM4Pie3NCVkeHUh?=
HNMn;6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4DQe2lEPTB;MUGuNVE{OSEQvF2=NYXpTG1LW0GQR1XS
NCI-H1304NWjwfZRWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfVTWM2OD1zMT6xOVc3KM7:TR?=NWnYcZBDW0GQR1XS
DaoyMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTFzLkSzN|Yh|ryPM2\hOnNCVkeHUh?=
VA-ES-BJMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFK4WY9KSzVyPUGxMlcyQTVizszNM13EUHNCVkeHUh?=
MCF7M{PKSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTFzLkixNlYh|ryPMkH6V2FPT0WU
VM-CUB-1NIHW[YdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfIbVhVUUN3ME2xNU46ODlzIN88US=>NHHVfnpUSU6JRWK=
IPC-298MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTFzLkmzPFMh|ryPNEjhcJRUSU6JRWK=
NCI-H2126NXjxTZhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvnTWM2OD1zMj6wNlE5KM7:TR?=MYPTRW5ITVJ?
OVCAR-8MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTF{LkGxOFEh|ryPNF73cWJUSU6JRWK=
SJRH30NUHvS|h7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTF{LkKyPVkh|ryPMXPTRW5ITVJ?
DMS-53M4HJ[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTF{LkK2OFkh|ryPMX7TRW5ITVJ?
NCI-H322MNYfhXnQ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV7tNZg4UUN3ME2xNk4{OzV5IN88US=>M2HmO3NCVkeHUh?=
RVH-421M3nwZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTF{LkS5NFQh|ryPMX7TRW5ITVJ?
RajiM3\tPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXtTWM2OD1zMj62NVQh|ryPMVzTRW5ITVJ?
MDA-MB-415MoX0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYPJR|UxRTF{Lk[0OFQh|ryPM{LE[XNCVkeHUh?=
EFE-184NEfOco9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\1e2RKSzVyPUGyMlcyODZizszNM3zyXXNCVkeHUh?=
BFTC-909M4TYUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHSzfJZKSzVyPUGyMlkzPDdizszNMoLPV2FPT0WU
BHYMmfTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHmwXHNKSzVyPUGzMlM{QSEQvF2=MXvTRW5ITVJ?
YKG-1NVHoSZc4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXyySXJ4UUN3ME2xN{4{PzR7IN88US=>NWXZPYdiW0GQR1XS
EW-3MnT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fuPGlEPTB;MUOuO|E3OyEQvF2=MoPRV2FPT0WU
HCC1143NX\uNHl[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnVXIZWUUN3ME2xN{44PDN5IN88US=>M3u5[XNCVkeHUh?=
REHMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDZOmZtUUN3ME2xN{45QTh{IN88US=>M4ri[nNCVkeHUh?=
CESSMoPzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXfiOmVNUUN3ME2xN{46PDh7IN88US=>MUfTRW5ITVJ?
EFM-19NHTvdlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXmTWM2OD1zND6xNVEzKM7:TR?=Ml7XV2FPT0WU
U031MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzXWVRKSzVyPUG0MlQxQDVizszNMVXTRW5ITVJ?
ES1MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmnDTWM2OD1zND60PFUyKM7:TR?=NVy3bYhpW0GQR1XS
HSC-3NIX2SXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrpTWM2OD1zND62NlE2KM7:TR?=MVzTRW5ITVJ?
LOXIMVIM{S3PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTF2LkewOlgh|ryPNHzmW4JUSU6JRWK=
A388NE\TdW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITRR2dKSzVyPUG0Mlc2PTZizszNNV20S4ZGW0GQR1XS
KP-N-YSMn\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4nte2lEPTB;MUSuO|c{KM7:TR?=MYTTRW5ITVJ?
Capan-2MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\JdGlEPTB;MUSuO|g3KM7:TR?=NXvBPWpKW0GQR1XS
SKG-IIIaMlHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LW[GlEPTB;MUSuPFg3OiEQvF2=Ml[3V2FPT0WU
HELM2nkZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mon3TWM2OD1zND64PVk4KM7:TR?=Mo\6V2FPT0WU
BENMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTF2Lkm3OlYh|ryPM3fGWnNCVkeHUh?=
MC116MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXnoO3hKUUN3ME2xOU4yPTl7IN88US=>M3;PUXNCVkeHUh?=
IGROV-1NUXqZ2c1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\zc2lEPTB;MUWuNlMyPyEQvF2=MVLTRW5ITVJ?
NCI-H1648NYPWVYJZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjaTWQ5UUN3ME2xOU42OzB3IN88US=>M2[yPHNCVkeHUh?=
ABC-1MkPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLSTWM2OD1zNT64NFM{KM7:TR?=NV;UZWl6W0GQR1XS
EW-18Mln3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojuTWM2OD1zNT65PVc6KM7:TR?=NXqzdnIzW0GQR1XS
BC-3NWX0S2p6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfCfHhKSzVyPUG2MlA2PjJizszNM{GyNHNCVkeHUh?=
NCI-H1437NVrlNm9xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTF4LkC2Olch|ryPNUTFSHNFW0GQR1XS
SCC-15MoLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTF4LkK4NlUh|ryPMWLTRW5ITVJ?
TTMmraS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTuTWM2OD1zNj61PFg5KM7:TR?=MXnTRW5ITVJ?
KINGS-1MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFiyTHFKSzVyPUG2MlgzPzNizszNMm\OV2FPT0WU
C32NILMTHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTF4Lkm3NVch|ryPM2SwWHNCVkeHUh?=
SBC-5M4fmNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TUPWlEPTB;MUeuNVQ4QSEQvF2=NVW3VIRWW0GQR1XS
NB1NVjDW28yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTF5LkOxPFgh|ryPMkHMV2FPT0WU
EB-3NV;vT4k3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXfEc481UUN3ME2xO{42PzZizszNMX;TRW5ITVJ?
NCI-H748MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYrqd4ZWUUN3ME2xO{44ODN3IN88US=>NYDlZYFkW0GQR1XS
IST-SL1M1PQV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HpTGlEPTB;MUeuO|UzPiEQvF2=MWfTRW5ITVJ?
WM-115M2XQVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUHnRndKUUN3ME2xO{45ODh3IN88US=>MUHTRW5ITVJ?
NCI-H226NXnVeHBKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFjNXZZKSzVyPUG3Mlk2PDZizszNMXXTRW5ITVJ?
CAL-33NIf6OVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTF6LkK3PFEh|ryPMoLQV2FPT0WU
SCC-4MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPZTWM2OD1zOD6zNlI6KM7:TR?=NF7ZNlFUSU6JRWK=
RMG-IMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17uUmlEPTB;MUiuOlk1PyEQvF2=M2PkOXNCVkeHUh?=
KOSC-2M3\6cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkLyTWM2OD1zOD63O|Q3KM7:TR?=NWr3UXlJW0GQR1XS
A2058M4XUT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LMbWlEPTB;MUiuPFI2PSEQvF2=NVfjW2VzW0GQR1XS
HCC70M{foT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\KfVJKSzVyPUG5MlM5QTRizszNM3zTcHNCVkeHUh?=
C2BBe1M2\5Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTF7LkSxOFgh|ryPMlvmV2FPT0WU
NCI-H650NV7CRmNsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVjJR|UxRTF7LkW4PVkh|ryPM{DIbHNCVkeHUh?=
CAL-72M{XpZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWO0c4FrUUN3ME2xPU43PzN5IN88US=>Ml7BV2FPT0WU
L-363M1TGO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\LTWM2OD1{MD6wNlEzKM7:TR?=MXXTRW5ITVJ?
SNU-423NEjxV29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnrFTWM2OD1{MD6xNFQ{KM7:TR?=MnTZV2FPT0WU
PLC-PRF-5MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\wTWM2OD1{MD6zPVA3KM7:TR?=NHHGW5RUSU6JRWK=
SW1463NHXGNWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYHJR|UxRTJyLkS1NlUh|ryPMkmyV2FPT0WU
769-PNVPhcFhOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTJyLk[3Olkh|ryPM{WyVHNCVkeHUh?=
DMS-79MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFr3fHVKSzVyPUKwMlg1QSEQvF2=NXvPfFRGW0GQR1XS
Saos-2MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHufVlNUUN3ME2yNE46PTV4IN88US=>MkDPV2FPT0WU
CHP-126M33xPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTJzLkS0OlIh|ryPNF7DWZFUSU6JRWK=
SW837NXKzS|dCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljXTWM2OD1{MT60PVM6KM7:TR?=MWnTRW5ITVJ?
SHP-77MlnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTJzLk[xNlIh|ryPMl\yV2FPT0WU
DBNGHaWHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH;XTGhKSzVyPUKxMlYyPDJizszNM{jiN3NCVkeHUh?=
ES5NUP0dIZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYT4WYZVUUN3ME2yNU43QDZ2IN88US=>Ml;vV2FPT0WU
COR-L23MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTJzLkiwOVEh|ryPNHvIeYRUSU6JRWK=
KU-19-19NHu3fYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{LtZ2lEPTB;MkGuPFk5OiEQvF2=NGW5RVRUSU6JRWK=
T84MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn[3TWM2OD1{MT65PFE6KM7:TR?=Mnf6V2FPT0WU
NCI-H630Mkj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfHPXlKSzVyPUKyMlU{PjNizszNNHLVb3NUSU6JRWK=
LU-165M3zBZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvLdWNKSzVyPUKyMlU2PCEQvF2=MWrTRW5ITVJ?
COLO-792MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnr1TWM2OD1{Mj63NVEyKM7:TR?=MWjTRW5ITVJ?
CAL-62NHfHc5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofETWM2OD1{Mj63OVE4KM7:TR?=M2mz[3NCVkeHUh?=
HCE-TMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTJ{Lki2NFYh|ryPNWPDXHBOW0GQR1XS
BB65-RCCNHTGNopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoCxTWM2OD1{Mz6wN|Q1KM7:TR?=M{jVNHNCVkeHUh?=
SiHaM4DtUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIjNWVNKSzVyPUKzMlM6PjhizszNNGnLO4lUSU6JRWK=
NCI-H2081MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTJ2LkC2OFEh|ryPMoqwV2FPT0WU
U251MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTJ2LkC2Olgh|ryPM2PjTXNCVkeHUh?=
LoVoMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjnS3o5UUN3ME2yOE46Ojh{IN88US=>NVP5cIdQW0GQR1XS
GCIYM1rjdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mkj2TWM2OD1{NT6yPFc4KM7:TR?=MoDEV2FPT0WU
NUGC-3MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlW3TWM2OD1{NT6zN|E3KM7:TR?=M2r5NnNCVkeHUh?=
LNCaP-Clone-FGCM3;QR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTJ3LkO0PVgh|ryPMX3TRW5ITVJ?
PA-1Mk\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTJ3Lk[4N|Mh|ryPNIHp[Y9USU6JRWK=
OE33MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLv[VdKSzVyPUK1MlY5PTNizszNNFXYUXlUSU6JRWK=
HT-29NVPqc2Q1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTJ3Lke4O|kh|ryPNF3vN49USU6JRWK=
RCM-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTJ3Lkm2OVYh|ryPNEX2WVFUSU6JRWK=
NCI-H1522NVrC[GJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXvTWM2OD1{NT65PVEyKM7:TR?=MXTTRW5ITVJ?
LB373-MEL-DMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH60bZJKSzVyPUK2MlE4ODhizszNMl;1V2FPT0WU
NCI-H1436MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV3JR|UxRTJ4LkK3N|gh|ryPMWrTRW5ITVJ?
COLO-824M3P5U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn22TWM2OD1{Nj60NFAzKM7:TR?=Ml60V2FPT0WU
CP50-MEL-BNYTCfpdpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYPSSGlPUUN3ME2yOk42Pjd3IN88US=>M1jxWXNCVkeHUh?=
EGI-1NFHmTZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13RUmlEPTB;MkeuNlY6QCEQvF2=M{nodnNCVkeHUh?=
LAN-6NXXLZXY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnlcnNKSzVyPUK3MlM2QThizszNMWfTRW5ITVJ?
GAKNF7Rem1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\KSVBKSzVyPUK3MlQzOjVizszNNXTXcIJQW0GQR1XS
MDA-MB-175-VIIMnPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIfzR2hKSzVyPUK3MlUxPTNizszNNXnDWXNSW0GQR1XS
JVM-2NGnTc4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnrWTWM2OD1{Nz62OlIzKM7:TR?=NX3CbHZLW0GQR1XS
UACC-257M4j2O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVfyZ3JoUUN3ME2yO{43QDd6IN88US=>NFHTR4RUSU6JRWK=
SW1783MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUOyO|YzUUN3ME2yO{44Pzh|IN88US=>NH3odVFUSU6JRWK=
HT-3M2\FcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4H6OmlEPTB;MkiuNlE3PiEQvF2=M1\TbnNCVkeHUh?=
RLMnrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTJ6LkW5NVEh|ryPMWLTRW5ITVJ?
TK10MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHXTWM2OD1{OD62OVM2KM7:TR?=MVHTRW5ITVJ?
HT55MmHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYf4fHdqUUN3ME2yPU4xPTZ3IN88US=>NETXTWlUSU6JRWK=
BT-20MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTJ7LkC1PFYh|ryPMlzuV2FPT0WU
TGBC24TKBMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TKcmlEPTB;MkmuNVg{OSEQvF2=M4XpeXNCVkeHUh?=
HSC-2M2\EXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2DxRWlEPTB;MkmuN|AxOSEQvF2=NVfEXIRNW0GQR1XS
COLO-205MlHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnr2TWM2OD1{OT6zPVQ1KM7:TR?=NHH3XXlUSU6JRWK=
GT3TKBMn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvvU3ZKSzVyPUK5MlY5PzdizszNMnLDV2FPT0WU
T47DM2XINWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1ficmlEPTB;MkmuPFU5OiEQvF2=MmTIV2FPT0WU
OMC-1M3;NPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvpTWM2OD1|MD6xPVE6KM7:TR?=MYTTRW5ITVJ?
PFSK-1Ml;aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIW3fIdKSzVyPUOxMlI3PTlizszNMV;TRW5ITVJ?
JEG-3MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrWTnFKSzVyPUOxMlM2PjFizszNMn:wV2FPT0WU
RDNGHrOpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXKT2NKUUN3ME2zNU42OTF3IN88US=>NUPrT5lRW0GQR1XS
NCI-H64NH75UmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPOXpBqUUN3ME2zNk41OTd7IN88US=>NH61[IZUSU6JRWK=
DMS-114M1vuRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvHTWM2OD1|Mj60NVgzKM7:TR?=NGWz[WZUSU6JRWK=
NCI-H661NFXRXoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1Xpd2lEPTB;M{KuOlUxOSEQvF2=NFnRXW1USU6JRWK=
CAL-148M3HBWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTN{Lk[2OlUh|ryPNYrjbndwW0GQR1XS
HuP-T3NXrUNmR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTN{LkmzN|gh|ryPNH7aNI1USU6JRWK=
ES4MlfKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWO5bZRvUUN3ME2zN{4yPzB3IN88US=>MVjTRW5ITVJ?
Ca9-22MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTN|LkS2NFEh|ryPNHfvXmtUSU6JRWK=
LP-1NYXOeWdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEW0W2NKSzVyPUO0MlA6KM7:TR?=MVjTRW5ITVJ?
AU565NYPM[2RmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XyNGlEPTB;M{SuOVA3QSEQvF2=M2\m[3NCVkeHUh?=
MDA-MB-453MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MleyTWM2OD1|NT6xOFI3KM7:TR?=MVvTRW5ITVJ?
SNU-C1NVz2cIJmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTN3LkG3NUDPxE1?M{\Fb3NCVkeHUh?=
SW13MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPURYFqUUN3ME2zOU41ODd4IN88US=>M3PJd3NCVkeHUh?=
NCI-H2122MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXz2T3BIUUN3ME2zOU42PTl6IN88US=>M4fMXXNCVkeHUh?=
NCI-H1395MljuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvPUIozUUN3ME2zOU43PjlzIN88US=>M3S4U3NCVkeHUh?=
J-RT3-T3-5NIG3UoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3TlWWlEPTB;M{[uNFI6PCEQvF2=NIj2O3pUSU6JRWK=
COR-L279NIW0TWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTN4LkG5PFEh|ryPMoPpV2FPT0WU
ATN-1MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmfxTWM2OD1|Nj64OVE3KM7:TR?=MXvTRW5ITVJ?
HCC2998NWnYeZZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYW5dI93UUN3ME2zOk45PTdzIN88US=>MX7TRW5ITVJ?
UM-UC-3MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGTT[5FKSzVyPUO2Mlg3PzVizszNNWPzU4I4W0GQR1XS
DV-90NELxeI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33RSWlEPTB;M{[uPVA3PyEQvF2=NFHqemtUSU6JRWK=
ES8MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\sSGlEPTB;M{[uPVMyQCEQvF2=M36yW3NCVkeHUh?=
YAPCMljqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTN4Lkm2OVQh|ryPMo\yV2FPT0WU
HCC1599M1XxZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnyyTWM2OD1|Nz6xOlE5KM7:TR?=MkHIV2FPT0WU
UMC-11MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTT[WxnUUN3ME2zO{4zPTB|IN88US=>MX;TRW5ITVJ?
THP-1NELUcVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIrCZ|FKSzVyPUO3MlI5PjhizszNMY\TRW5ITVJ?
OCUB-MMnrMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nmOGlEPTB;M{euNlg6OSEQvF2=MkK1V2FPT0WU
NCI-H1693MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXRPYpzUUN3ME2zO{4{OjN|IN88US=>MWXTRW5ITVJ?
NCI-H345NGTQfXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\GTWM2OD1|Nz6zOlI1KM7:TR?=Moi2V2FPT0WU
COLO-800NF\MV|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTN5LkW2O{DPxE1?NFfJ[XhUSU6JRWK=
COLO-320-HSRMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTN6LkO0PVIh|ryPMW\TRW5ITVJ?
NCI-H596M3\Pe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHqToVKSzVyPUO4MlQ1QDlizszNMon5V2FPT0WU
NCI-H187M{L1Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYO1d2RrUUN3ME2zPE44OzR2IN88US=>NX;LNGZbW0GQR1XS
ECC4MonBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXj2R|U3UUN3ME2zPU4xQDF2IN88US=>M3GyVnNCVkeHUh?=
KP-4M2X5Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYe3T|VmUUN3ME2zPU4yOjN3IN88US=>MlnmV2FPT0WU
NCI-H2227NWrSfYNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HtXGlEPTB;M{muN|k1QSEQvF2=M2jmO3NCVkeHUh?=
22RV1NFvxU|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTN7LkizPVgh|ryPMXPTRW5ITVJ?
SASMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1XY[2lEPTB;NECuNFk3KM7:TR?=Mln6V2FPT0WU
PANC-10-05MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vQWmlEPTB;NECuNVgzQCEQvF2=NF3zfIZUSU6JRWK=
MDA-MB-468M2\4R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTqeHhKSzVyPUSwMlU{PDZizszNM3K5bnNCVkeHUh?=
RPMI-7951MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH30TmtKSzVyPUSxMlIxPzVizszNNYG3TXBIW0GQR1XS
BB49-HNCM3\BfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLubI1KSzVyPUSxMlIyPzlizszNMlrLV2FPT0WU
23132-87NUXsTYZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTRzLkK3N|Ih|ryPNXLiXIN1W0GQR1XS
HCC1569NYLHSoZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPmTWM2OD12MT6yPFg2KM7:TR?=M1LUUXNCVkeHUh?=
CP66-MELM3HKbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\HSmlEPTB;NEKuNVg5PiEQvF2=M17MZXNCVkeHUh?=
K-562MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjXRlhKSzVyPUSyMlI5PTRizszNMVrTRW5ITVJ?
OCI-AML2MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2fNNWlEPTB;NEKuPFk4PCEQvF2=NF7mSVhUSU6JRWK=
SW756M3f2OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2G0TmlEPTB;NEOuNFM5QCEQvF2=MYPTRW5ITVJ?
M14NWPRTZAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXrUeYlvUUN3ME20N{4{OTh7IN88US=>M13vPHNCVkeHUh?=
NCI-H1623M2WybGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\CTWM2OD12Mz60OlQh|ryPMWfTRW5ITVJ?
KNS-81-FDM{nXV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTR|Lke2NkDPxE1?MojiV2FPT0WU
TGBC1TKBNVvvflNUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\LS|hmUUN3ME20N{46ODl7IN88US=>MknpV2FPT0WU
RERF-LC-MSMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HHZ2lEPTB;NEOuPVI5OSEQvF2=M3XMeHNCVkeHUh?=
PC-3NV3yeo1NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLY[3VMUUN3ME20OE41OzR5IN88US=>MWfTRW5ITVJ?
HuP-T4NUnSfnp1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjy[GFKSzVyPUS0MlQ1PzRizszNNYXlTmQ6W0GQR1XS
NCI-H510ANXfNWZR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTR2LkewPEDPxE1?M2LnWnNCVkeHUh?=
LB2518-MELMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfKTWM2OD12ND63PVM4KM7:TR?=MlnrV2FPT0WU
TE-5MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjZR5RKSzVyPUS1Mlk2QDFizszNMnu2V2FPT0WU
EW-24NWSwNldLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHFOGtKSzVyPUS2MlE4OjNizszNNHjGOVVUSU6JRWK=
LB647-SCLCMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7G[49KSzVyPUS2MlIyPTVizszNMWHTRW5ITVJ?
NCI-H524NF7VPYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4f0b2lEPTB;NE[uO|E5PSEQvF2=NI\tNmhUSU6JRWK=
EW-11NU\lSY9{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTZXGtKSzVyPUS2Mlk{PzNizszNNYrMNVBvW0GQR1XS
KALS-1M1rhW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfPTWM2OD12Nz6yNFY3KM7:TR?=NFvWOW5USU6JRWK=
BT-474MkLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXLYN2xQUUN3ME20O{41OjF4IN88US=>M2LiZXNCVkeHUh?=
SK-N-ASMm\CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvMTWM2OD12Nz64PFgh|ryPMoq4V2FPT0WU
HCC2157Mn;vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRTR6LkC3OkDPxE1?MXrTRW5ITVJ?
HCC1954NXLSSHZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTR6LkG3NFQh|ryPNUnQ[ohKW0GQR1XS
FADUM2HSd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PoO2lEPTB;NEiuN|A{OSEQvF2=MoDKV2FPT0WU
S-117M1LKWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MontTWM2OD12OD6zPFE2KM7:TR?=MYPTRW5ITVJ?
LS-1034MlPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnzuTWM2OD12OD63NFY4KM7:TR?=MmDmV2FPT0WU
CAMA-1M3HDSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrWXXRKSzVyPUS5MlU2PDNizszNMXTTRW5ITVJ?
LU-134-ANXLWS215T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnwTGw3UUN3ME20PU45ODh3IN88US=>MonFV2FPT0WU
NCI-H1838M4O3bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDKfI5KSzVyPUS5MlgxQDdizszNM3TxZnNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02829840 Not yet recruiting Leukemia|FLT3-Mutated Acute Myeloid Leukemia|FLT3-Mutated High-Risk Myelodysplastic Syndrome M.D. Anderson Cancer Center|Ariad Pharmaceuticals September 2016 Phase 1|Phase 2
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Frequently Asked Questions

  • Question 1
    Is the pre-solubilized inhibitor suitable for in vivo whole animal studies? Whether the solvent contains any non-DMSO stabilizer?

    Answer: Our 10mM Ponatinib in DMSO solution is in pure DMSO and there is not other stabilizer added. You can use it for animal study. The vehicle we suggest for Ponatinib is: 30% PEG400/0.5% Tween80/5% Propylene glycol. It is a milky suspension used for oral gavage.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us